Ventum Cap Mkts Decreases Earnings Estimates for Cresco Labs

Cresco Labs Inc. (OTCMKTS:CRLBFFree Report) – Research analysts at Ventum Cap Mkts lowered their FY2024 EPS estimates for shares of Cresco Labs in a research report issued to clients and investors on Monday, November 11th. Ventum Cap Mkts analyst A. Semple now expects that the company will earn ($0.17) per share for the year, down from their previous estimate of ($0.16). Ventum Cap Mkts has a “Strong-Buy” rating on the stock. The consensus estimate for Cresco Labs’ current full-year earnings is ($0.19) per share. Ventum Cap Mkts also issued estimates for Cresco Labs’ FY2025 earnings at ($0.08) EPS.

Other equities analysts have also recently issued research reports about the company. Cormark cut Cresco Labs from a “moderate buy” rating to a “hold” rating in a report on Monday. Needham & Company LLC reissued a “hold” rating on shares of Cresco Labs in a research note on Monday, August 12th. Finally, Roth Capital raised shares of Cresco Labs to a “strong-buy” rating in a research note on Sunday, November 10th. Three equities research analysts have rated the stock with a hold rating, two have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Cresco Labs presently has a consensus rating of “Moderate Buy” and a consensus target price of $2.50.

View Our Latest Stock Report on Cresco Labs

Cresco Labs Trading Down 2.8 %

CRLBF opened at $1.40 on Thursday. The company has a debt-to-equity ratio of 1.76, a quick ratio of 1.30 and a current ratio of 2.00. The stock’s 50 day moving average price is $1.58 and its 200-day moving average price is $1.70. Cresco Labs has a one year low of $1.02 and a one year high of $2.65. The stock has a market cap of $683.40 million, a price-to-earnings ratio of -7.20 and a beta of 1.88.

About Cresco Labs

(Get Free Report)

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.

See Also

Earnings History and Estimates for Cresco Labs (OTCMKTS:CRLBF)

Receive News & Ratings for Cresco Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cresco Labs and related companies with MarketBeat.com's FREE daily email newsletter.